Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-Announces-That-The-American-Journal-of-Gastroenterology-Publishes-Full-Results-from-Positive-LINZESS-linaclotide-Phase-IIIb-Trial-in-Adults-with-Irritable-Bowel-Syndrome-with-Constipation-IBS-C/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here